Abstract PO2-09-09: Racial/Ethnic Differences in Survival of Male Patients with Stage I-III Breast Cancer by Hormone Receptor Status Using Real-World Data
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs23-po2-09-09
Abstract: Background: Male breast cancer (BC) is rare and accounts for < 1.0% of all BCs in the US. Given its rarity and limited data, racial/ethnic differences in survival outcomes among men with early-stage BC (EBC)… read more here.
Keywords: cancer; breast cancer; white pts; status ... See more keywords
Abstract PS9-04: Evaluating racial genomic differences in de novo metastatic breast cancer utilizing ctDNA: results from a large multi-center consortium
Sign Up to like & getrecommendations! Published in 2025 at "Clinical Cancer Research"
DOI: 10.1158/1557-3265.sabcs24-ps9-04
Abstract: Background: Prior studies have shown that Black patients (pts) are more likely to present with de novo metastatic breast cancer (mBC) compared to White pts and have worse survival outcomes. Our prior research demonstrated some… read more here.
Keywords: pts novo; breast cancer; novo mbc; white pts ... See more keywords
Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.4_suppl.376
Abstract: 376 Background: The prognostic value of pathologic variables is not consistent for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). We previously demonstrated a limited prognostic role of lymph node (LN) positivity in small bowel NETs (SBNET) compared to… read more here.
Keywords: race; black pts; pathology; white pts ... See more keywords
Impact of race on biomarker testing among HER2- advanced breast cancer (ABC) patients (pts) in the United States: Results from a real-world study.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.10598
Abstract: 10598 Background: African Americans (AA) have the highest breast cancer (BC) mortality rate. Access to treatment is a known contributing factor. In the past 4 years, several targeted therapies for HER2- BC have become available… read more here.
Keywords: race; testing rates; cancer; white pts ... See more keywords
Effects of socioeconomic status (SES) and healthcare resource (HCR) availability on survival in Black patients (pts) versus (vs) White pts with multiple myeloma (MM): A SEER Medicare analysis.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e13678
Abstract: e13678 Background: In MM, disparities exist for overall survival (OS) by race, and many factors may contribute to these differences. This study evaluates whether SES and HCR availability impacts OS in older pts with newly… read more here.
Keywords: white pts; black pts; hcr availability; availability ... See more keywords
Impact of race on outcomes to 177Lu-PSMA-617 (LuPSMA) for metastatic castrate-resistant prostate cancer (mCRPC).
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.4_suppl.27
Abstract: 27 Background: Prior work suggests that African American (AA) and other minority patients (pts) derive equal benefit from taxane chemotherapy and androgen receptor pathway inhibitors (ARPIs) for mCRPC as white pts. LuPSMA showed an overall… read more here.
Keywords: minority pts; mcrpc; lupsma; minority ... See more keywords
Real-world (RW) analysis of characteristics and risk of recurrence (ROR) in Black patients (pts) with HR+/HER2− early breast cancer (EBC) eligible for NATALEE.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.527
Abstract: 527 Background: The NATALEE trial showed statistically significant and clinically meaningful invasive disease–free survival benefit with ribociclib + nonsteroidal aromatase inhibitor (NSAI) vs NSAI alone in pts with stage II/III HR+/HER2− EBC at high ROR… read more here.
Keywords: survival; ror; white pts; black pts ... See more keywords